Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108976123B details a Pd-catalyzed method for axial chiral allenes with 90-96% ee. Enables cost-effective synthesis of pharmaceutical intermediates and natural products like traumatic lactone.
Patent CN108727246B details a metal-free visible light method for indole C3 alkylation using organic dyes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105001666B details water-soluble NIR dye synthesis. Enhances protein detection stability and offers scalable manufacturing for supply chains.
Patent CN100548965C details scalable synthesis of optically pure omega-hydroxy acid derivatives from steroidal sapogenin waste, offering cost-effective chiral building blocks.
Patent CN114181120A reveals a phosgene-free route for p-toluenesulfonyl isocyanate. Achieve >95% yield and enhanced safety for diabetes drug manufacturing.
Patent CN111072625A reveals a novel diatomite-catalyzed route for 3,4-methylenedioxyacetophenone, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN107417583B reveals metal-free allyl sulfone synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN102875275B reveals a safe copper-catalyzed method for aryl nitriles. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates globally.
Novel three-step synthesis avoids malodorous reagents. Ensures high purity and scalable production for pharmaceutical intermediates. Cost-effective and supply chain reliable.
Discover the novel copper-catalyzed synthesis of N-sulfonyl imine coumarins. High purity, mild conditions, and scalable routes for API intermediates.
Patent CN112778218A reveals a green method for quinazolinone derivatives using recyclable chitosan-copper catalyst, offering cost reduction and supply chain reliability.
Patent CN110894188B reveals a novel etherification method suppressing isomers, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel visible-light copper catalyzed synthesis for high-purity alkynyl phosphate intermediates. Offers mild conditions and scalable production for pharmaceutical supply chains.
Patent CN120098034A reveals a neutral photocatalytic route for 1,2-bisphosphonoethane compounds, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110590525A reveals scalable manganese-catalyzed route reducing costs and enhancing supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel copper-catalyzed one-pot synthesis offers high yield and purity for complex heterocycles, ensuring cost-effective supply chain solutions.
Patent CN119118766B reveals hydrophilic carbon catalyst for deuterated intermediates. Enables cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover the novel preparation method for 1,2,3,6-tetrahydrophthalimide via patent CN110642774A. Achieve higher purity and cost reduction in pharmaceutical intermediates manufacturing.
Novel one-step synthesis patent CN118084697A offers high yield and cost efficiency for glufosinate intermediates, ensuring reliable supply chain performance.
Patent CN111718286A reveals a greener, continuous production method for aromatic sulfonyl chlorides, offering significant cost reduction and enhanced supply chain reliability for fine chemical manufacturers.